Advanced ovarian cancer: Three-year results of a 6–8 month, 2-drug cisplatin-containing regimen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advanced ovarian cancer: Three-year results of a 6–8 month, 2-drug cisplatin-containing regimen

Published:1987-06 Issue:6 Volume:23 Page:631-641
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Piccart Martin J.,Speyer James L.,Wernz James C.,Noumoff Joel,Beller Uziel,Beckman Mark,Dubin Neil,Demopoulos Rita,Muggia Franco

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Cyclophosphamide plus cis-platinum in combination;Decker,1982

2. A randomized trial of Melphalan alone versus combination chemotherapy in advanced ovarian cancer;Śturgeon,1982

3. Diammindichloroplatinum based combination chemotherapy is superior to Melphalan for advanced ovarian cancer;Vogl,1982

4. Randomized trial comparing two combination chemotherapy regimens (HEXA-CAF vs. CHAP-5) in advanced ovarian carcinoma;Neijt;The Lancet,1984

5. A randomized trial of cyclophosphamide plus adriamycin with or without cisplatin in ovarian carcinoma;Omura,1982

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum compounds: Their continued impact on ovarian cancer treatment;Inorganica Chimica Acta;2019-10

2. Principles of Systemic Therapy;Textbook of Medical Oncology, Fourth Edition;2009-09-12

3. Expression of the Cell Cycle Inhibitor p27KIP1 Is a New Prognostic Marker Associated with Survival in Epithelial Ovarian Tumors;The American Journal of Pathology;1999-01

4. Meta-analysis Comparing Cisplatin Total Dose Intensity and Survival;Gynecologic Oncology;1995-10

5. Intraperitoneal High-Dose Cisplatin and Etoposide with Systemic Thiosulfate Protection in Second-Line Treatment of Advanced Ovarian Cancer;Gynecologic Oncology;1993-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3